Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000505462 | SCV000599678 | pathogenic | Familial X-linked hypophosphatemic vitamin D refractory rickets | 2013-11-06 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000505462 | SCV001141517 | likely pathogenic | Familial X-linked hypophosphatemic vitamin D refractory rickets | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001051990 | SCV001216175 | pathogenic | not provided | 2023-02-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 29393334). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 438544). This variant has been observed in individual(s) with hypophosphatemic rickets (PMID: 21902834, 29393334, 30682568). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 197 of the PHEX mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PHEX protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. |
Revvity Omics, |
RCV000505462 | SCV002018776 | pathogenic | Familial X-linked hypophosphatemic vitamin D refractory rickets | 2022-03-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000505462 | SCV005726061 | pathogenic | Familial X-linked hypophosphatemic vitamin D refractory rickets | 2024-11-21 | criteria provided, single submitter | clinical testing | Variant summary: PHEX c.591A>G alters a non-conserved nucleotide resulting in a synonymous change. Several computational tools predict a significant impact on normal splicing: Three predict the variant creates a 5' donor site. Two predict the variant creates a 3' acceptor site. Three predict the variant abolishes a cryptic 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing in patient samples (example, Cao_2022, Liao_2018) by deleting 77 bp from the 3' end of exon 5, resulting in a predicted frameshift (example, Cao_2022, Liao_2018). mRNA expression data from patient samples indicated female carriers have approximately half PHEX mRNA levels of wild type controls, suggesting nonsense mediated decay (Liao_2018), but results in male hemizygous sample(s) were unclear. The variant was absent in 183360 control chromosomes. c.591A>G has been reported in the literature in the heterozygous or hemizygous state in multiple related individuals affected with X-Linked Hypophosphatemic Rickets (example, Cao_2022, Liao_2018). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 35842615, 29393334). ClinVar contains an entry for this variant (Variation ID: 438544). Based on the evidence outlined above, the variant was classified as pathogenic. |